AT2101: Clinical Trials

1 trial of AT2101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow AT2101: new trials by email Literature Review of AT2101 trials Research Report on AT2101

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101
AT2101 - Type 1 Gaucher Disease
Phase 1TerminatedAmicus Therapeutics12009-04-012010-08-19

Conditions studied

Gaucher Disease (1)

Sponsors

Amicus Therapeutics (1)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

Eugene Schneider, MD (1)